Tender detail
Supply of Ruxience preparation
Summary
The tender concerns the supply of the medicinal product Ruxience (antineoplastic agents). The estimated value is EUR 776,944 and the procedure is open. The machine-readable notice did not include precise participation requirements; these must be checked in the tender documents and the official additional information.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.